跳至主要内容
临床试验/PACTR202310525672884
PACTR202310525672884尚未招募4 期

Analgesic effectiveness of wound infiltration with bupivacaine and a mixture of bupivacaine and tramadol for postoperative pain management among participants undergoing elective cesarean section under spinal anesthesia at Dilla university general hospital, 2023: a double-blind randomized controlled trial

Dilla University0 个研究点目标入组 60 人开始时间: 2023年9月19日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • ?Pregnant mothers between 18 and 45
  • ?ASA class =II

排除标准

  • ?Patients with known allergies to bupivacaine and tramadol
  • ?History of alcohol usage, opiate or other drug abuse
  • ?Pregnant mothers who diagnosed with Chronic pain
  • ?Pregnant mothers with systemic diseases like renal impairment, chronic liver disease, chronic obstructive pulmonary disease, and cardiac disease
  • ?Pregnant mothers with pre-eclampsia, eclampsia
  • ?Spinal anesthesia with adjuvants
  • ?Operation other than the lower uterine segment incision
  • ?Pregnant mothers taking opioids preoperatively

研究者

相似试验